The Distinguished Lecture Series at Trivedi School of Biosciences (TSB) at Ashoka brings noted speakers to the university to encourage and enlighten learners, faculty, and the community with diverse perspectives and topics of thought. Learn more Embedded within the Department of Biology at Ashoka, Trivedi School of
Biosciences is established using generous philanthropic donation by
the Founder and Trustee Ashok Trivedi.
We focus on emerging and frontier areas of Biosciences with three interconnected and interdisciplinary research centers – Center for Disease Biology, Center for Inflammation Biology and Center for Synthetic Biology. Learn more Our approach focuses on creating a unique identity for our educational goals and research themes, also in the processes and practises defined to achieve these goals. We aspire to be the best ‘School of Biosciences’ in India in the next five years, and the best in Asia in a decade. About us Three interconnected and interdisciplinary research centers – Center for Disease Biology, Center for Inflammation Biology and Center for Synthetic Biology – that will carry out cutting edge research and support the training of future leaders.

Our Programs

Ashoka’s strength lies in its quality faculty across disciplines, decorated with prestigious academic research awards. Our focus centres towards natural sciences, social sciences and humanities, computing and data sciences, and more.

Our Advisory Board and Leadership

Our Scientific Advisory Board comprises of global bioscience leaders advising on the establishment of and goal-setting for the TSB. Our quality extends to our faculty, expected to cut across at least two of three verticals for their research.

Our Advisory Board and Leadership

Our Scientific Advisory Board comprises of global bioscience leaders advising on the establishment of and goal-setting for the TSB. Our quality extends to our faculty, expected to cut across at least two of three verticals for their research.

Why Biosciences in India?

India’s software industry is estimated to have provided 15 million jobs and raised the country’s global profile. For biotechnology the global market forecast is estimated at $471 bn by 2025. India is presently among the top 12 global biotechnology destinations and is 3rd in the Asia Pacific region. It had a market size of $11.6 bn in 2017, but aspires to reach $100 bn by 2025 with enabling government policies, and public and private capital. This will provide a 21st century opportunity for brand building and job creation to India.

But there are gaps. While it has the 2nd highest numbers of FDA-approved manufacturing plants, India still commands only a meagre 2% of the global biotechnology business. Generation of knowledge and its translation into products and processes will be required to fill this gap and propel India forward in this sector.